Oltipraz-induced amelioration of acetaminophen hepatotoxicity in hamsters: II. Competitive shunt in metabolism via glucuronidation

https://doi.org/10.1016/0041-008X(91)90188-KGet rights and content

Abstract

Previously, we demonstrated that oltipraz [OTP: 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] prevented the hepatotoxicity of acetaminophen (AAP) in hamsters and that the observed protection was not related to increases in hepatic reduced glutathione (GSH) levels. These experiments were designed to elucidate the mechanism of OTP-induced protection with respect to an apparent non-GSH-dependent system. Marked differences in the relative amounts of hepatic GSH content depleted by AAP in control vs OTP-treated hamsters occurred. Urinary recoveries of AAP and metabolites indicated that more AAP-glucuronide was formed at the expense of other major metabolites (AAP-GSH, -N-acetylcysteine, and -sulfate) in OTP-treated hamsters, while plasma toxicokinetic modeling suggested a greater rate of AAP systemic clearance. An increased apparent formation rate constant for AAP glucuronidation (135%), in concert with significantly lower apparent formation rate constants for those metabolites which reflect the production of the reactive intermediate from AAP (glutathione and N-acetylcysteine), provide the rationale for this shift of metabolism. The biochemical basis for metabolic shunting is significantly elevated hepatic UDP-glucuronic acid content, an increased calculated UDP-glucuronic acid synthetic rate, and an increased liver microsomal UDP-glucuronyl transferase activity in OTP-treated animals. These changes in AAP conjugation were concomitant with decreased fractional clearance of AAP via bioactivation and less in vivo AAP covalent binding. These data support the hypothesis that OTP provides a protecting effect from AAP hepatotoxicity due to an augmented and predisposing glucuronidation capacity.

References (43)

  • J. Singh et al.

    Dependence of glucuronidation rate on UDP-glucuronic acid levels in isolated hepatocytes

    Biochem. Pharmacol.

    (1981)
  • J.B. Watkins et al.

    Determination of hepatic uridine 5′-diphosphoglucuronic acid by conjugation with diethylstilbestrol

    J. Pharmacol. Methods

    (1982)
  • D. Acosta et al.

    Cytotoxicity of acetaminophen and paraverine in primary cultures of rat hepatocytes

    Toxicol. Appl. Pharmacol.

    (1980)
  • E. Albano et al.

    Mechanisms of N-acetyl-p-benzoquinoneimine cytotoxicity

    Mol. Pharmacol.

    (1985)
  • H.M. Ali et al.

    Diet-controlled blood levels of oltipraz in healthy male subjects

    J. Antimicrob. Chemother.

    (1984)
  • H. Akaiki

    A new look at statistical model identification

    IEEE Trans. Autom. Control.

    (1973)
  • S.S. Ansher et al.

    Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity

    Hepatology

    (1983)
  • B.A. Bieder et al.

    Comparison of the metabolism of oltipraz in the mouse, rat and monkey, and in man

    Arzneim. Forsch. Drug Research

    (1983)
  • R.D. Brown et al.

    ESTRIP, A basic computer program for obtaining initial polyexponential parameter estimates

    J. Pharm. Sci.

    (1978)
  • G.B. Corcoran et al.

    Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-l-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice

    J. Pharmacol. Exp. Ther.

    (1986)
  • G.B. Corcoran et al.

    Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice

    J. Pharmacol. Exp. Ther.

    (1985)
  • Cited by (14)

    • Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers

      2004, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
    • Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi

      2003, Journal of Biological Chemistry
      Citation Excerpt :

      It is clear from these studies of JNK activity that deletion of GSTP does not affect how the cell responds to the chemical stress induced by APAP; rather it primes the cell, through increased JNK signaling, to be better equipped to deal with such a chemical insult. Consequently the small changes in the constitutive expression of both hepatic HO-1 and UGT1A6 (genes that are known to protect against APAP hepatotoxicity (17, 24, 48–52)) will contribute to the protection observed in GstP1/P2(–/–) mice against acetaminophen hepatotoxicity. However, these changes cannot fully explain the phenotypic differences in hepatic GSH levels seen previously (27).

    View all citing articles on Scopus
    1

    Current address: Bristol-Myers Squibb Co., Department of Pathology/Toxicology, Syracuse, NY 13221.

    View full text